C84.94
Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code C84.94 refers to mature T-cell and natural killer (NK) cell lymphomas that primarily affect the lymph nodes in the axillary (armpit) region and upper limbs. These are types of non-Hodgkin lymphomas, which are cancers originating from lymphocytes, a kind of white blood cell crucial for the immune system. The classification 'unspecified' indicates that precise subtyping of the lymphoma has not been detailed in this particular diagnosis. Individuals diagnosed with this condition should seek comprehensive medical evaluation to determine the appropriate course of action and understand the nature of their diagnosis.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocyte growth and development Environmental exposures, such as certain chemicals or pesticides Chronic immune system stimulation or autoimmune diseases Viral infections, including Epstein-Barr virus (EBV) and human T-lymphotropic virus (HTLV) Previous radiation therapy or chemotherapy treatments Age-related cellular changes, typically in middle-aged and older adults
Key Symptoms: Painless swelling or enlargement of lymph nodes in the axillary or upper limb areas Unexplained weight loss Persistent fever without infection Night sweats Fatigue and weakness Itching or skin changes over affected lymph nodes Possible discomfort or pressure sensation in the affected regions
Diagnostic & Treatment
Diagnosis Path: To diagnose this type of lymphoma, a healthcare professional will typically perform a combination of methods, including: - Physical examination of lymph node regions - Imaging studies such as CT scans or PET scans to identify enlarged lymph nodes and assess the extent of disease - Blood tests to evaluate overall health and immune function - Lymph node biopsy to examine the tissue microscopically, guiding precise classification - Immunophenotyping and molecular studies to determine the specific subtype of T/NK-cell lymphoma Diagnosis is crucial for devising an effective treatment plan and understanding prognosis.
Treatment Protocols: Treatment plans for mature T/NK-cell lymphomas generally involve a combination of approaches, tailored to the individual’s disease characteristics and overall health. Common options include: - Chemotherapy regimens aimed at destroying cancerous lymphocytes - Targeted therapies designed to interfere with specific molecules involved in lymphoma growth - Radiation therapy to target affected lymph nodes - Stem cell transplantation in selected cases to restore healthy blood cells after high-dose therapy - Supportive care to manage symptoms and side effects As this is an unspecified subtype, treatment decisions depend heavily on detailed pathological and clinical assessments. It is essential that patients discuss their options with specialized healthcare providers to understand the potential benefits and risks associated with each treatment approach.
Clinical Advice & FAQs
Billing Guidance
Is C84.94 a billable ICD-10 code?
Yes, C84.94 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.94?
Clinical documentation must specify the nature of Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference